Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Aliment Pharmacol Ther. 2017 Aug 16;46(7):645–656. doi: 10.1111/apt.14253

Table 2.

Characteristics of excluded studies

Study Year Reasons for exclusion
Seidman et al. 1991 abstract only
Seidman et al. 1993 abstract only
Thomas et al. 1992 wrong outcome
Thomas et al. 1993 no patient level data
Breese et al. 1995 poor classification of steroid exposre
Terrin et al. 2002 poor drug classification, no information on disease distribution
Ruuska et al. 1994 wrong outcome, no discussion of randomization
Soo et al. 2013 80% of EEN group on AZA and 64% on 5-ASA, not a clean comparison of EEN vs. CS
Saadah et al. 2012 combines data from EEN and CS arm, not a true comparator two armed study
Gorard et al. 2003 adult population
Mesker et al. 2009 no EN only comparator arm
Zhu et al. 2013 adult population
Hartmann et al. 2008 no EN only comparator arm
Sigall-Boneh et al. 2014 no non-diet treatment arm
Workman et al. 1984 no non-diet treatment arm
Harries et al. 1983 adult population
Riordan et al. 1993 adult population
Matsumoto et al. 2005 no EN only comparator arm, adult population

AZA, azathioprine; 5-ASA, mesalamine; EEN, exclusive enteral nutrition; EN, Enteral Nutrition; CS, corticosteroids